Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseasesFrancisco M. De La Vega, Stephen F. Kingsmore, Shimul Chowdhury et al.|Genome Medicine|2021Cited by 154
Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory SyndromeHratch Baghdassarian, Lori Broderick, Sarah A. Blackstone et al.|New England Journal of Medicine|2023Cited by 78
Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNADavid Haan, Samuel Levy, Bill Gibb et al.|Clinical Gastroenterology and Hepatology|2023Cited by 40
Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Using Cell-Free DNA 5-Hydroxymethylation SignaturesDavid Haan, Samuel Levy, Anna Bergamaschi et al.|medRxiv|2021Cited by 3